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Cardiovascular diseases (CVDs) are the leading cause 
of death worldwide[1] and the leading cause of non-
communicable disease morbidity and mortality in 
South Africa (SA).[2,3] The main drivers of the CVD 
burden in the country include urbanisation, increased 
tobacco use, poor diets associated with high cholesterol, and diabetes, as 
well as a general lack of physical activity leading to overweight/obesity. [2,4] 
CVD mortality in SA is primarily a result of myocardial infarction, 
stroke, congestive heart failure, cardiomyopathy and diseases related to 
high blood pressure.[3] CVD-related morbidity is often a consequence 
of angina, atherosclerosis, coronary artery disease, cardiomyopathy 
and rheumatic heart disease (RHD),[3,5] with RHD being especially 
prevalent in underprivileged children below the age of 15 years.[5] It is 
estimated that between 1997 and 2004, 33 people died per day in SA 
from myocardial infarction, 37 per day from heart failure and 60 per day 
from stroke,[3] while there were approximately 130 myocardial infarction 
and 240 stroke survivors each day over the same period.
Cardiovascular medical devices are tools that can be employed for 
the diagnosis, monitoring, surgical intervention, therapy or prosthetic 
treatment of cardiovascular conditions;[6] they can potentially impact on 
CVD morbidity and mortality. In 2007, the World Health Organization 
implemented the priority medical devices project[7] with the aim 
of redirecting resources towards combating high-burden diseases 
such as CVD by improving medical device access, quality, clinical 
relevance and use. The 2006 guidelines of the National Department 
of Health[2] also encouraged collaboration for more focused medical 
device development. Previous work[6] has shown that there has been 
a general increase in collaboration for cardiovascular medical device 
development in SA since 2000, as indicated by journal publications. 
However, the focus of this published activity has not been explored.
Identification of cardiovascular 
medical device focus areas
We examined the focus of SA cardiovascular medical device research 
over the period 2000 - 2014. Journal articles discussing CVDs in the 
SA context were collected using methods and criteria detailed in 
previous work.[6] The journal articles were accessed using PubMed 
and Web of Science. An article was included in the study if at least one 
of the authors had an SA affiliation, it had been published between 1 
January 2000 and 31 December 2014, and it described a contribution 
to the development (and not just the clinical use) of a device or a 
new application of an existing device. A set of 122 articles satisfied 
these criteria.
Two approaches were used to identify the research focus areas of 
the journal articles. One approach classified each article based on the 
CVD, condition or structure addressed by the device. The second 
involved assigning a category to each article in a similar manner 
to the Code of Federal Regulations Title 21 of the US Food and 
Drug Administration,[8] namely diagnostic, monitoring, therapeutic, 
surgical or prosthetic device. Diagnostic devices and monitoring 
devices were combined into a single class, since medical devices that 
play a diagnostic role are also often used for monitoring purposes. 
Prosthetic devices included any implantable device intended for 
correcting CVD conditions, while surgical devices were those 
intended for CVD surgical interventions. Finally, therapeutic devices 
were those that assist in the management of CVD.
Diseases and conditions addressed
Fig. 1 shows the types of disease, condition or cardiovascular struc-
ture addressed.
Valvular heart diseases were most commonly addressed and 
accounted for 18% of the articles. Examples include the development 
of a percutaneous aortic heart valve,[9] numerical simulation of the 
behaviour of aortic valves[10] and the application of finite element 
methods to improve stent design for a percutaneous heart valve.[11] 
Similar in proportion to valvular devices were devices for vascular 
diseases (17%), addressing conditions related to blood vessels. A 
large proportion of the devices (12%) were classified as ‘nonspecific’ 
as these either addressed several aspects of the cardiovascular system 
or did not clearly define the disease, structure or condition addressed.
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Myocardial infarction and high blood press-
ure, which are among the leading contri butors 
to cardiovascular deaths in SA, accounted for 
8% and 6% of the articles, respectively, while 
heart failure and thrombo embolic ischaemic 
stroke each accounted for only 2%. None of 
the articles captured addressed rheumatic 
heart disease, which is a prevalent heart 
condition among children from low-income 
settings in SA.[3,5]
Clinical applications
An alternative approach to understanding 
the focus of cardio vascular medical device 
research entailed classifying the articles 
based on their clinical applications. Research 
on development of cardiovascular devices 
was more focused on devices intended 
for diagnosis, monitoring or prosthetic 
treatment than on therapeutic or surgical 
devices. Nearly half (48%) of the articles 
described the development of diagnostic 
and monitoring devices, and just over one-
third (35%) discussed the development 
of prosthetic devices. Therapeutic and 
surgical devices jointly accounted for 17% 
of the articles. Examples of diagnostic and 
monitoring devices drawn from published 
articles include new applications for electro-
cardiograms, artery waveform analysers 
and phonocardiograms. These devi ces 
addressed vascular and valvular diseases. 
Prosthetic devices included vein grafts and 
heart valves, related also to vascular and 
valvular diseases.
Influence of foreign 
collaborators
From the 122 articles in this study, 298 
authors were affiliated to 51 SA organisations, 
with an additional 166 authors affiliated to 
97 foreign organisations. The affiliations of 
the first and last authors were determined 
for each publication, as it was assumed 
that if either of these authors had an SA 
affiliation, the research could be considered 
to be locally driven.
Approximately 89% of the articles had 
a first and/or last author affiliated with 
an SA organisation, suggesting that despite 
foreign organisations outnumbering local 
organisations, the research focus was still 
largely dictated by local organisations. In 
addition, although fewer local organisations 
were represented in the publications, 
approximately three times more local 
than foreign authors were represented per 
organisation.
Conclusion
The focus of cardiovascular medical dev-
ice research in SA has been examined 
using journal articles published between 
2000 and 2014. The findings suggest that 
diag nostic and monitoring cardiovascular 
devices as well as prosthetic devices receive 
more attention in SA than surgical and 
therapeutic devices. The main structures 
addressed are heart valves and blood vessels. 
This is consistent with a high incidence of 
atherosclerosis, which is one of the major 
causes of cardiovascular morbidity in SA.
The majority of the articles examined were 
led by authors with SA affiliations, confirm-
ing strong local capacity in cardiovascular 
medical device research.
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Fig. 1. Diseases, conditions or structures addressed by cardiovascular medical device research in 
SA between 2000 and 2014. The number of articles is shown next to each bar. The x-axis gives the 
proportion of articles as a percentage of all relevant search results. (*ALCAPA = anomalous origin of 
the left coronary artery from the pulmonary artery.)
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